Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine ind...
Leadership
Thomas Lingelbach
President, CEO & Director
Peter Buhler
Chief Financial Officer
Juan-Carlos Jaramillo M.D.
Chief Medical Officer
Dipal Patel
Chief Commercial Officer
Vincent Dequenne
Chief Operating Officer
Hanneke Schuitemaker Ph.D.
Chief Scientific Officer
Joshua Drumm Ph.D.
Vice President of Investor Relations
Kendra Wergin
General Counsel & Corporate Secretary
Laetitia Bachelot-Fontaine
VP of Global Communications & European Investor Relations
